Eli Lilly and Company
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
Last updated:
Abstract:
The present invention provides novel intermediates and processes useful in the manufacture of tirzepatide, or a pharmaceutically acceptable salt thereof.
Status:
Application
Type:
Utility
Filling date:
28 Jan 2020
Issue date:
5 May 2022